구독하기
연구 모델
서비스
전임상 효능 평가
Resource
Vil1-MerCreMer Mouse
제품 견적 요청
카탈로그에서 제품을 선택하여 요청을 제출해 주세요. Cyagen 팀이 상세 정보를 제공해 드립니다.
Vil1-MerCreMer Mouse
제품명
Vil1-MerCreMer Mouse
제품 ID
C001433
품종 계통
C57BL/6JCya-Igs2em1(Vil1-MerCreMer)/Cya
Backgroud
C57BL/6JCya
상태
이 마우스 계통을 논문에서 사용할 경우, “Vil1-MerCreMer Mouse (카탈로그 번호 C001433)은 Cyagen에서 구입하였습니다.”라고 명시해 주시기 바랍니다.
Inducible Cre Mouse Models
구매 가능한 제품 종류
연령
Genotype
성별
수량
표준 제공 조건은 최소 3마리의 이형접합(heterozygous) 보균자를 보장합니다. 동형접합(homozygous) 보균자 및/또는 특정 성별에 대한 브리딩 서비스도 제공됩니다.
가격 문의
Inducible Cre Mouse Models
기본 정보
검증 데이터
관련 자료
기본 정보
유전자명
유전자 별칭
Vil
NCBI ID
염색체
Chr 1
MGI ID
Datasheet
품종 계통 설명
The VIL1 gene encodes the Villin 1 protein, which belongs to the calcium-regulated actin-binding protein family and is a major part of the brush border cell cytoskeleton, playing a role in actin filament capping, severing, and bundling. Villin 1 is an epithelial cell-specific Ca(2+)-regulated actin-modifying protein that regulates the reorganization of microvillar actin filaments, playing a role in actin nucleation, actin filament bundle assembly, actin filament capping, and severing. VIL1 is selectively expressed in epithelial cells in the gastrointestinal tract, gallbladder, and renal tubules.
Vil1-MerCreMer mice were generated by inserting a Tamoxifen-inducible Cre recombinase protein MerCreMer gene expression element controlled by the mouse Vil1 promoter into the mouse H11 safe harbor site. Before induction, MerCreMer is only present in the cytoplasm and can only enter the nucleus to exert its recombination effect after Tamoxifen treatment. When bred with mice containing a loxP site-flanked sequence, Cre recombinase-mediated deletion of the flanked sequence will occur in the villous and crypt epithelial cells of the small and large intestines of the offspring after Tamoxifen induction. The onset of endogenous mouse Vil1 gene expression is at 9.0dpc, and the onset of Cre recombinase expression in this strain is approximately 12.5dpc.
변형 전략
The “Mouse Vil1 promoter-MerCreMer-rBG pA” gene expression element was inserted into the H11 locus.

Figure 1. Schematic diagram of gene editing in Vil1-MerCreMer mice.
검증 데이터
1. Method
Vil1-MerCreMer mice were crossed with Rosa26-LSL-tdTomato mice to generate double heterozygous offspring. At 6 weeks of age, these offspring were subjected to Tamoxifen induction via intraperitoneal injection at a dose of 75 mg/kg for 5 consecutive days. This resulted in Cre recombinase-mediated deletion of LSL elements and subsequent expression of tdTomato in Cre-positive cells. One week after induction, tissues from the intestines, stomach, ureters, kidneys, ovaries, uterus, epididymis, and testes were collected from the offspring. The distribution of tdTomato was determined by immunofluorescence staining to assess the expression of Cre recombinase.
2. Groups
Cre+Tam+: Vil1-MerCreMer[KI/+];Rosa26-LSL-tdTomato[CKI/+], with Tamoxifen;
Cre+Tam-: Vil1-MerCreMer[KI/+];Rosa26-LSL-tdTomato[CKI/+], without Tamoxifen.
3. Result
(1)Expression of Cre recombinase in the small intestinal tissues
The presence of abundant tdTomato-positive signals in the crypts and intestinal villus epithelial cells of the duodenum, jejunum, and ileum in Cre+Tam+ mice indicates strong expression of Cre recombinase in the small intestine. In contrast, no tdTomato expression or Cre recombinase activity was observed in these tissues in the non-tamoxifen-induced group.

Figure 2. Immunofluorescence staining of duodenal, jejunal, and ileal tissues.
(2)Expression of Cre recombinase in the large intestinal tissues
The presence of abundant tdTomato-positive signals in the crypts and intestinal villus epithelial cells of the cecum, colon, and rectum in Cre+Tam+ mice indicates strong expression of Cre recombinase in the large intestine.

Figure 3. Immunofluorescence staining of the cecum, colon, and rectum tissues.
(3)Expression of Cre recombinase in the stomach, ureter, and kidney
The presence of a small amount of tdTomato-positive signal in kidney and stomach cells of Cre+Tam+ mice indicates trace expression of Cre recombinase. However, no such expression was observed in the ureter.

Figure 4. Immunofluorescence staining of the gastric, ureteric, and renal tissues.
(4)Expression of Cre recombinase in the female gonads
The absence of tdTomato signals in the uterus and ovaries of Cre+Tam+ mice suggests that there is no Cre recombinase activity at these sites, and therefore no germline deletion of the target gene.

Figure 5. Immunofluorescence staining of the uterus and ovary.
(5)Expression of Cre recombinase in the male gonads
The presence of only minimal amounts of tdTomato-positive signal in the testis and epididymis of Cre+Tam+ mice suggests that the likelihood of Cre recombinase expression leakage at these sites is extremely low, and therefore does not result in germline deletion of the target gene.

Figure 6. Immunofluorescence staining of the testicular and epididymal tissues.
4. Summary
In Vil1-MerCreMer mice, the expression of Cre recombinase was primarily localized to the crypts and intestinal villus epithelial cells of both the large and small intestines. Only a small amount of Cre recombinase activity was detected in certain cells of the kidney and stomach, while no expression was observed in the ureters. Furthermore, Cre recombinase activity was virtually absent in the gonads, indicating a low likelihood of germline leakage. This model represents a highly tamoxifen-inducible, tissue-specific Cre mouse line targeting intestinal crypts and intestinal villus epithelial cells.
관련 자료
1:1 상담
문의 사항이나 도움이 필요하신가요? <br> 아래 양식을 작성해 주시면 Cyagen 팀이 1~2 영업일 이내에 답변드리겠습니다.
관련 제품
모든 관련 제품리소스
출판물
Nature Communications
2025-04-05
Colonic epithelial-derived FGF1 drives intestinal stem cell commitment toward goblet cells to suppress inflammatory bowel disease
자세히 보기
The EMBO Journal
2026-03-17
The WNK-OXSR1 osmosensing pathway mediates intestinal regeneration via Hippo-YAP signaling.
자세히 보기
Items: 1 to 2 of 2
1
문의하기
맞춤형 동물 모델 관련 상담을 위해 Cyagen 전문가와 연락해 보세요. 아래 양식을 작성하여 상담을 시작하거나 견적을 요청하시기 바랍니다.
Cyagen은 고객님의 개인정보를 소중히 여깁니다. 최신 제품, 서비스 및 인사이트를 안내드리고자 합니다. 고객님의 수신 설정은 다음과 같습니다:
해당 커뮤니케이션은 언제든지 수신 거부하실 수 있습니다. 수신 거부 방법 및 데이터 보호에 대한 자세한 내용은 개인정보처리방침을 참고해 주시기 바랍니다.
아래 버튼을 클릭함으로써, 요청하신 콘텐츠 제공을 위해 본 양식을 통해 제출된 개인정보를 Cyagen이 저장 및 처리하는 데 동의하게 됩니다.
